Literature DB >> 24274898

New Delhi metallo-β-lactamase-1 in carbapenem-resistant Salmonella strain, China.

Jinwei Huang, Minghua Wang, Hui Ding, Meiping Ye, Fupin Hu, Qinglan Guo, Xiaogang Xu, Minggui Wang.   

Abstract

Entities:  

Keywords:  China; New Delhi metallo-β-lactamase-1 NDM-1; Salmonella spp.; acute diarrhea; antimicrobial resistance; bacteria; carbapenem; carbapenem resistance; carbapenemase; plasmid-mediated

Mesh:

Substances:

Year:  2013        PMID: 24274898      PMCID: PMC3840890          DOI: 10.3201/eid1912.130051

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Carbapenem resistance in Enterobacteriaceae can occur through the production of carbapenem-hydrolyzing enzymes such as New Delhi metallo-β-lactamase-1 (NDM-1) (). In recent years, plasmid-mediated NDM-1 has spread rapidly worldwide and into multiple Enterobacteriaceae species, such as Klebsiella pneumoniae and Escherichia coli (). NDM-1 has been reported in 2 strains of Salmonella spp., which were isolated from feces and urine specimens during screening for multidrug-resistant bacteria in patients from India (,). We report the isolation of 1 community-acquired NDM-1–bearing Salmonella strain isolated from a child with acute diarrhea. The Salmonella strain was isolated from the feces of an 11-month-old girl at Lishui Central Hospital, Zhejiang Province, China, on July 25, 2012. Six days before admission, a fever ≤40°C, accompanied by a cough, developed in the patient. Four days before admission, physical examination showed fine rales in both lungs. The leukocyte count was 8,900 cells/µL, with 80% neutrophils. No obvious abnormalities were found on a chest radiograph. The patient was given a diagnosis of acute bronchitis, and the condition was treated with parenteral cefoxitin for 3 days and parenteral piperacillin/tazobactam for 1 day, but fever persisted. Two days before admission, diarrhea (4–5 times/day with loose feces containing mucus and blood) developed. On admission day, fecal analysis showed 3–4 leukocytes and 1–3 erythrocytes per high-power field. A Salmonella sp. was isolated from feces obtained at admission and identified as S. enterica subsp. enterica serovar Stanley by serotyping by the local Centers for Disease Control and Prevention. The patient was then given a diagnosis of bacterial enteritis and received intravenous azithromycin and latamoxef. Fever and diarrhea resolved over the next 3 days. On the fifth day of hospitalization, a fecal culture was negative for Salmonella spp. and the patient was discharged. At a follow-up visit 3 months later, Salmonella spp. or other carbapenem-resistant bacteria were not isolated from feces samples from the patient or her grandmother and brother, who lived with her. The patient and her family had not traveled to any country during the year, including countries with a high prevalence of NDM-1 producers. The patient was living in a small rural village in southern China and did not have a special diet. She was healthy before hospitalization for fever. She was born by cesarean section and did not have contacts with hospitalized patients. MICs of antimicrobial drugs were determined by agar dilution and interpreted by using revised Clinical and Laboratory Standards Institute breakpoints (). The Salmonella Stanley strain was resistant to all β-lactam antimicrobial drugs tested, including cephalosporins and carbapenems, but susceptible to chloramphenicol, ciprofloxacin, tetracycline, and fosfomycin, and had azithromycin MICs of 4 µg/mL (Table).
Table

Antimicrobial drug susceptibility of Salmonella strain Stanley and transconjugants containing New Delhi metallo-β-lactamase-1, China

Drug
MIC, μg/mL
A modified Hodge test result for Salmonella strain Stanley was weakly positive. Production of metallo-β-lactamase was detected by using an imipenem-EDTA double-disk synergy test. Carbapenamase-encoding genes, including blaKPC-2, blaVIM, blaIMP, blaSPM-1, blaGIM-1, and blaSIM-1, were detected by using PCR as described (). Only the blaNDM-1 gene was detected (with primers 5′-GGCGGAATGGCTCATCACGA-3′ and 5′-CGCAACACAGCCTGACTTTC-3′). The PCR product sequence was consistent with that of NDM-1 (GenBank accession no. FN396876). Conjugation experiments were conducted as described (). Carbapenem resistance could be transferred from Salmonella strain Stanley to E. coli C600 Rifr and K. pneumoniae 13883 Rifr at frequencies of 1 transconjugant per ≈1.0 × 104 and 4.0 × 107 bacterial cells, respectively, after exposure for 15 min. Plasmid DNA was extracted by using a Plasmid Midi Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s instructions. Electrophoresis showed that donor and transconjugant strains had the same plasmid profile; both contained an ≈140-kb plasmid. A PCR-based method for plasmid replicon typing () indicated that the plasmid belonged to incompatibility group IncA/C. Experiments of blaNDM-1 stability in Salmonella spp., E. coli transconjugants, and K. pneumoniae transconjugants were conducted by using the method of Wang et al. (). Twenty colonies were randomly selected every day during days 2–15. Only 2 colonies of the Salmonella Stanley strain lost carbapenem resistance; these colonies were collected on the second and ninth days of passage, respectively. Plasmids containing blaNDM-1were not present in these 2 colonies. No transconjugants lost carbapenem resistance during 14 days of passage. Although Salmonella spp. have shown increased resistance to cephalosporins and quinolones, resistance to carbapenems is rare (,,,). Because of emerging resistance to traditionally recommended antimicrobial agents, azithromycin is increasingly used for treatment of invasive Salmonella spp. infections in children (). The patient with carbapenem-resistant Salmonella infection and acute diarrhea was cured by treatment with azithromycin. This report indicates ongoing spread of NDM-1–bearing Salmonella strains. If one considers the high conjugation frequency and stability of the IncA/C plasmid containing NDM-1 in Salmonella spp., one would conclude that it might increase spread of bacterial drug resistance. Prompt recognition of carbapenem-resistant Salmonella spp. and initiation of appropriate infection control measures are essential to avoid spread of these organisms.
  9 in total

Review 1.  The emerging NDM carbapenemases.

Authors:  Patrice Nordmann; Laurent Poirel; Timothy R Walsh; David M Livermore
Journal:  Trends Microbiol       Date:  2011-11-09       Impact factor: 17.079

2.  First NDM-positive Salmonella sp. strain identified in the United States.

Authors:  Patrice Savard; Ramya Gopinath; Wenming Zhu; Brandon Kitchel; J Kamile Rasheed; Tsigereda Tekle; Ava Roberts; Tracy Ross; Jafar Razeq; B Mark Landrum; Lucy E Wilson; Brandi Limbago; Trish M Perl; Karen C Carroll
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

3.  Emergence of Klebsiella pneumoniae and Salmonella metallo-beta-lactamase (NDM-1) producers on reunion island.

Authors:  Florian Cabanes; Jérome Lemant; Sandrine Picot; Catherine Simac; Julien Cousty; Laurence Jalin; Florence Naze; Véronique Boisson; Marie-Pierre Cresta; Hélène André; Laure Thibault; François Tixier; Arnaud Winer; Emmanuel Antok; Alain Michault
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

4.  Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates from the United States.

Authors:  Maria Sjölund-Karlsson; Kevin Joyce; Karen Blickenstaff; Takiyah Ball; Jovita Haro; Felicita M Medalla; Paula Fedorka-Cray; Shaohua Zhao; John A Crump; Jean M Whichard
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

5.  Development of carbapenem resistance during therapy for non-typhoid Salmonella infection.

Authors:  L H Su; T L Wu; C H Chiu
Journal:  Clin Microbiol Infect       Date:  2012-02-13       Impact factor: 8.067

6.  Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.

Authors:  Dongeun Yong; Mark A Toleman; Christian G Giske; Hyun S Cho; Kristina Sundman; Kyungwon Lee; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

7.  Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China.

Authors:  Minggui Wang; John H Tran; George A Jacoby; Yingyuan Zhang; Fu Wang; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

8.  IncA/C plasmids: An emerging threat to human and animal health?

Authors:  Timothy J Johnson; Kevin S Lang
Journal:  Mob Genet Elements       Date:  2012-01-01

9.  Ciprofloxacin-resistant Salmonella enterica serotype Typhimurium, China.

Authors:  Shenghui Cui; Jingyun Li; Ziyong Sun; Changqin Hu; Shaohong Jin; Yunchang Guo; Lu Ran; Yue Ma
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

  9 in total
  11 in total

1.  First report of blaNDM and blaOXA-58 coexistence in Acinetobacter junii.

Authors:  Handal Regeen; Dalia Al-Sharafa-Kittaneh; Randa Kattan; Rula Al-Dawodi; Hiyam Marzouqa; Musa Y Hindiyeh
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

2.  Synthesis of metallo-β-lactamase VIM-2 is associated with a fitness reduction in Salmonella enterica Serovar Typhimurium.

Authors:  Nicolás F Cordeiro; José A Chabalgoity; Lucía Yim; Rafael Vignoli
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

3.  Clinical isolates of Salmonella enterica serovar Agona producing NDM-1 metallo-β-lactamase: first report from Pakistan.

Authors:  Seema Irfan; Erum Khan; Kauser Jabeen; Pushpa Bhawan; Katie L Hopkins; Martin Day; Amna Nasir; Daniele Meunier; Neil Woodford
Journal:  J Clin Microbiol       Date:  2014-11-05       Impact factor: 5.948

Review 4.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

5.  Draft Genome Sequence of a Multidrug-Resistant bla NDM-1-Producing Acinetobacter soli Isolate in China.

Authors:  Yan Chen; Zhengsong Yan; Miaojuan Wang; Xia Zheng; Yun Lu; Shaohua Lin
Journal:  Indian J Microbiol       Date:  2014-05-22       Impact factor: 2.461

6.  Retail chicken giblets contaminated with extended-spectrum cephalosporin- and carbapenem-resistant Salmonella enterica carrying blaCMY-2.

Authors:  Fatma Abdel-Kader; Eman Hamza; Khaled A Abdel-Moein; Maha A Sabry
Journal:  Vet World       Date:  2022-05-25

7.  Characterization of a blaNDM‑1‑harboring plasmid from a Salmonella enterica clinical isolate in China.

Authors:  Jinwei Huang; Shanshan Deng; Jianmin Ren; Jianfei Tu; Meiping Ye; Minggui Wang
Journal:  Mol Med Rep       Date:  2017-06-08       Impact factor: 2.952

8.  Genomic characterization of a large plasmid containing a bla NDM-1 gene carried on Salmonella enterica serovar Indiana C629 isolate from China.

Authors:  Wei Wang; Zulqarnain Baloch; Zixin Peng; Yujie Hu; Jin Xu; Séamus Fanning; Fengqin Li
Journal:  BMC Infect Dis       Date:  2017-07-07       Impact factor: 3.090

9.  Coexistence of bla NDM-1 and rmtC on a Transferrable Plasmid of a Novel ST192 Klebsiella aerogenes Clinical Isolate.

Authors:  Xiaofei Shen; Li Liu; Jingyi Yu; Xingwei Cao; Qing Zhan; Yinjuan Guo; Liangxing Wang; Fangyou Yu
Journal:  Infect Drug Resist       Date:  2019-12-13       Impact factor: 4.003

Review 10.  Resistance to Carbapenems in Non-Typhoidal Salmonella enterica Serovars from Humans, Animals and Food.

Authors:  Javier Fernández; Beatriz Guerra; M Rosario Rodicio
Journal:  Vet Sci       Date:  2018-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.